https://ibmm.umontpellier.fr/wp-content/uploads/2026/09/Capture-decran-2026-09-16-201033.png
465
780
Caroline Clavel
https://ibmm2.umontpellier.fr/wp-content/uploads/logo_ibmm_hd.jpg
Caroline Clavel2026-09-16 21:37:222026-09-16 21:37:22JIREC 2026 featured in L’Actualité ChimiqueNews
https://ibmm.umontpellier.fr/wp-content/uploads/2026/09/Capture-decran-2026-09-16-201033.png
465
780
Caroline Clavel
https://ibmm2.umontpellier.fr/wp-content/uploads/logo_ibmm_hd.jpg
Caroline Clavel2026-09-16 21:37:222026-09-16 21:37:22JIREC 2026 featured in L’Actualité Chimique
https://ibmm.umontpellier.fr/wp-content/uploads/2026/09/Capture-decran-2026-09-08-154324.png
527
1007
Caroline Clavel
https://ibmm2.umontpellier.fr/wp-content/uploads/logo_ibmm_hd.jpg
Caroline Clavel2026-09-08 16:09:102026-09-08 16:09:10HyriaMed: a new start-up stemming from research by the PHBM teamEvents
16 research teams
Nucleosides & Phosphorylated Effectors
Amino acids, heterocycles, peptides & proteins
ChemBioNAC
Bioactive Lipids Syntheses
Supramolecular MAchines and ARchitecture Team
Cellular pharmacology
Pharmacochemistry Synaptic Transmission & Neuroprotection
Polymers for Health and Biomaterials
Oncotherapy and Oncopharmacology
Glycochemistry & molecular recognition
Green Chemistry and Enabling Technologies
Glyco and nanovectors for therapeutic targeting
Analytical Sciences of Biomolecules
Oncopharmacochemy & Skin Pharmacotoxicology
Dynamics of Complex Biomolecular Systems
6 months intership : Role of the Ghrelin System in Weight Gain in Patients with Breast Cancer
Background Unlike many other types of cancer, which are often associated with weight loss, patients with breast cancer may experience weight gain following diagnosis. This phenomenon, which remains poorly understood, represents an important public health issue. It is associated with an increased risk of mortality, both through the risk of cancer recurrence and through the […]
6 months Internship: Controlled and targeted photothermal delivery of CDK4 inhibitors by Prussian Blue nanoparticles into cellular and ex ovo models of pancreatic cancer.
Pancreatic cancer (PC) has a less than 1% overall 10-year survival rate and is typically diagnosed at an advanced stage with limited treatment options. Surgical resection remains the only potentially curative treatment, generally followed by adjuvant chemotherapy. For non-resectable metastatic PC, current chemotherapy regimens provide limited benefit and are associated with significant toxicity. In addition, […]